ZBH — Bearish (ASignal Rank 4/4)
ASignal's 10+ AI agent pipeline rates ZBH as Bearish with 72% confidence in the Healthcare sector.
AI Analysis Summary
ZBH presents significant risks due to extreme leverage and deteriorating fundamentals, warranting a bearish stance despite defensive healthcare sector positioning.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade D — 25/100
- Bill Ackman (Activist Investing): Grade C — 50/100
- Ray Dalio (Macro/Risk Parity): Grade C — 55/100
Consensus: Bearish
Price Intelligence
- Current price: $91.26
- Price target: $89.32 (-2.1%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: good
- Competitive moat: none
Peer Group Analysis
ZBH is in the “Oversold & Compressed” cluster alongside XOM, WFC, WDAY, VLO, VTR (128 stocks total). 0 of 128 peers are currently bullish.